Page 1
Page 1
Started By
Message

Alright, who invested in Tobira (TBRA) today- up 719% as of noontime

Posted on 9/20/16 at 11:06 am
Posted by NYNolaguy1
Member since May 2011
20900 posts
Posted on 9/20/16 at 11:06 am
LINK

quote:



NEW YORK (TheStreet) -- Shares ofAllergan (AGN) were falling in early-morning trade Tuesday after the pharmaceutical company agreed to buyTobira Therapeutics (TBRA) for as much as $1.695 billion.

Allergan will pay $28.35 per share in cash, or up to $49.84 per share if Tobira hits certain development, regulatory and sales goals.

Tobira is a biopharmaceutical company developing therapies for non-alcoholic fatty liver disease.

If Tobira fails to meet contingency goals, the lower deal price still represents a roughly 500% premium over its closing price yesterday of $4.74 per share.




LINK
Posted by MSMHater
Houston
Member since Oct 2008
22775 posts
Posted on 9/20/16 at 11:08 am to
quote:

developing therapies for non-alcoholic fatty liver disease.


I don't know anything about either company, but that is a very large and growing market.
Posted by dabigfella
Member since Mar 2016
6687 posts
Posted on 9/20/16 at 11:14 am to
isnt that NASH what GILD was after?
Posted by MSMHater
Houston
Member since Oct 2008
22775 posts
Posted on 9/20/16 at 12:15 pm to
quote:

isnt that NASH what GILD was after?


Correct. But I don't think it ever made it to market. And it was more to treat the cirrhosis caused by NASH.
first pageprev pagePage 1 of 1Next pagelast page
refresh

Back to top
logoFollow TigerDroppings for LSU Football News
Follow us on Twitter, Facebook and Instagram to get the latest updates on LSU Football and Recruiting.

FacebookTwitterInstagram